Kim; Sang Geon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kim; Sang Geon.The latest application filed is for "novel compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient".

Company Profile

0.7.10

Kim; Sang Geon - Seoul KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient Grant 9,745,280 - Suh , et al. August 29, 2	2017-08-29
Novel Compound Or Pharmaceutically Acceptable Salt Thereof, And Pharmaceutical Composition Containing Same As Active Ingredient App 20160340331 - SUH; Young-Ger ; et al.	2016-11-24
Pharmaceutical composition containing 1,2-dithiolthione derivative for preventing or treating disease caused by overexpression of LXR-.alpha. Grant 9,370,504 - Kim , et al. June 21, 2	2016-06-21
Pharmaceutical composition comprising metadoxine and garlic oil for preventing and treating alcohol-induced fatty liver and steatohepatitis Grant 8,158,170 - Kim , et al. April 17, 2	2012-04-17
Pharmaceutical Composition Containing 1,2-dithiolthione Derivative For Preventing Or Treating Disease Caused By Overexpression Of Lxr-alpha App 20110152524 - Kim; Sang Geon ; et al.	2011-06-23
Pharmaceutical Composition Comprising Metadoxine and Garlic Oil For Preventing and Treating Alcohol-Induced Fatty Liver and Steatohepatitis App 20100062090 - Kim; Sang Geon ; et al.	2010-03-11
Composition Comprising Liquiritigenin for Preventing and Treating Liver Disease App 20090232919 - Kim; Sang Geon ; et al.	2009-09-17
4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds Grant 7,435,819 - Kim , et al. October 14, 2	2008-10-14
4,5,6,7-Tetrahydro-[1,2]Dithiolo[4,3-C] Pyridine-3-Thione Compounds App 20080058368 - Kim; Sang-Geon ; et al.	2008-03-06
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis Grant 7,078,045 - Kim , et al. July 18, 2	2006-07-18
Pharmaceutical composition for regeneration of cirrhotic liver App 20060063781 - Kim; Sang-Geon ; et al.	2006-03-23
Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz App 20030191137 - Kim, Sang-Geon ; et al.	2003-10-09
Pharmaceutical composition for regeneration of cirrhotic liver App 20030171382 - Kim, Sang-Geon ; et al.	2003-09-11
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis App 20030161877 - Kim, Sang-Geon ; et al.	2003-08-28
Anti-cancer compositions Grant 5,891,864 - Han , et al. April 6, 1	1999-04-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.